Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.

Dearnaley, D P; Horwich, A; A'Hern, R; Nicholls, J; Jay, G; Hendry, W F; Peckham, M J

Dearnaley, D P; Horwich, A; A'Hern, R; Nicholls, J; Jay, G; Hendry, W F; Peckham, M J.

Affiliation

Dearnaley DP; Department of Radiotherapy and Oncology, Royal Marsden Hospital, Sutton, Surrey, U.K.

Eur J Cancer ; 27(6): 684-91, 1991.

Article in En | MEDLINE | ID: mdl-1712606

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Teratoma/secondary; Testicular Neoplasms/drug therapy; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bleomycin/administration & dosage; Bleomycin/adverse effects; Cisplatin/administration & dosage; Cisplatin/adverse effects; Combined Modality Therapy; Etoposide/administration & dosage; Etoposide/adverse effects; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Teratoma/drug therapy; Teratoma/mortality; Teratoma/surgery; Testicular Neoplasms/mortality

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Teratoma / Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 1991 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links